| Authors: |
Enriquez C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cancila V; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Italy., Ferri R; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sulsenti R; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fischetti I; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Milani M; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ostano P; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy., Gregnanin I; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy., Mello-Grand M; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy., Berrino E; Department of Medical Sciences, University of Turin, Turin, Italy.; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Bregni M; Oncology-Hematology Unit, ASST Valle Olona, Busto Arsizio, Italy., Renne G; Division of Uropathology and Intraoperative Consultation, IEO, European Institute of Oncology IRCCS, Milan, Italy., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Italy., Colombo MP; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. elena.jachetti@istitutotumori.mi.it mariopaolo.colombo@istitutotumori.mi.it., Jachetti E; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. elena.jachetti@istitutotumori.mi.it mariopaolo.colombo@istitutotumori.mi.it. |